Assessing susceptibility to cardiac intervention, susceptibility to therapy for heart failure, risk of mortality or further cardiovascular events, and risk of subsequent pulmonary embolism in relevant patients based on determinations of GDF-15, natriuretic peptide, cardiac troponin or combinations thereof
授权日
2015-02-10
公开(公告)号
US8951742
申请日
2009-02-02
公开(公告)日
2015-02-10
当前申请(专利权)人
MEDIZINISCHE HOCHSCHULE HANNOVER
发明人
WOLLERT, KAI C. | KEMPF, TIBOR | WALLENTIN, LARS | DREXLER, HELMUT